To gain further insights into biological differences associated with varying ITPR2 expression levels, genome-wide analysis of microRNA expression profiles were exploited using high throughput sequencing of 79 CN-AML patients from The Cancer Genome Atlas (TCGA) [24]. Here, ITPR2 is linked to acute myeloid leukemia.